 | • レポートコード：MRC2-11QY12006 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胃食道逆流症（GERD）治療薬のグローバル市場について調査・分析したレポートです。種類別（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI））市場規模、用途別（胸やけ、酸逆流症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胃食道逆流症（GERD）治療薬の競争状況、市場シェア ・世界の胃食道逆流症（GERD）治療薬市場：種類別市場規模 2015年-2020年（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI）） ・世界の胃食道逆流症（GERD）治療薬市場：種類別市場規模予測 2021年-2026年（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI）） ・世界の胃食道逆流症（GERD）治療薬市場：用途別市場規模 2015年-2020年（胸やけ、酸逆流症） ・世界の胃食道逆流症（GERD）治療薬市場：用途別市場規模予測 2021年-2026年（胸やけ、酸逆流症） ・北米の胃食道逆流症（GERD）治療薬市場分析：米国、カナダ ・ヨーロッパの胃食道逆流症（GERD）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胃食道逆流症（GERD）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胃食道逆流症（GERD）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胃食道逆流症（GERD）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Eisai、GSK、Takeda、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.
Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attributable for the downfall of this market.
Market Analysis and Insights: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market
The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is projected to reach US$ 4765.6 million by 2026, from US$ 4733.1 million in 2020, at a CAGR of 0.6%% during 2021-2026.
Global Gastroesophageal Reflux Disease (GERD) Therapeutics Scope and Market Size
Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
…
Market segment by Type, the product can be split into
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Market segment by Application, split into
Heartburn
Acid reflux disorders
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antacids
1.4.3 Pro-kinetic agents
1.4.4 H2 Receptor Blockers
1.4.5 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Heartburn
1.5.3 Acid reflux disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2015-2026)
2.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastroesophageal Reflux Disease (GERD) Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Market Size
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
3.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2019
3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
3.5 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
6.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
7.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
8.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in China (2019-2020)
8.3 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
8.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
9.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
10.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in India (2019-2020)
11.3 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
11.4 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
12.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview
13.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 GSK
13.3.1 GSK Company Details
13.3.2 GSK Business Overview
13.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.3.5 GSK Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gastroesophageal Reflux Disease (GERD) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
Table 3. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antacids
Table 6. Key Players of Pro-kinetic agents
Table 7. Key Players of H2 Receptor Blockers
Table 8. Key Players of Proton Pump Inhibitors (PPIs)
Table 9. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Gastroesophageal Reflux Disease (GERD) Therapeutics Players
Table 20. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2019)
Table 23. Global Gastroesophageal Reflux Disease (GERD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
Table 26. Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 36. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 38. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 42. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 48. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 50. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 54. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 66. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 68. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2019-2020)
Table 72. Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2020)
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Product
Table 79. AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020) (Million US$)
Table 80. AstraZeneca Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Product
Table 84. Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020) (Million US$)
Table 85. Eisai Recent Development
Table 86. GSK Company Details
Table 87. GSK Business Overview
Table 88. GSK Product
Table 89. GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020) (Million US$)
Table 90. GSK Recent Development
Table 91. Takeda Company Details
Table 92. Takeda Business Overview
Table 93. Takeda Product
Table 94. Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020) (Million US$)
Table 95. Takeda Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antacids Features
Figure 3. Pro-kinetic agents Features
Figure 4. H2 Receptor Blockers Features
Figure 5. Proton Pump Inhibitors (PPIs) Features
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Heartburn Case Studies
Figure 8. Acid reflux disorders Case Studies
Figure 9. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Figure 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2019
Figure 17. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
GERD・NERD治療の世界市場（～2026年） Over the last two hundred years, acid reflux has been a common lifestyle problem and also experienced a few setbacks in the U.S. Though, the ultimate goal of the gastroesophageal reflux treatment has always remained the same, which is to suppress the symptoms of the GERD patient. GERD affects up to …- 胃食道逆流症（GERD）の世界市場（～2026年） Gastroesophageal reflux disease involves the backflow of stomach’s content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its ela…
- アルツハイマー病治療薬の世界市場（～2026年） Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 冠動脈疾患治療薬の世界市場（～2026年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…
- 逆流性腎症治療の世界市場（～2026年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …